Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,80k | 136,35k | Vente | 75,75 | 7,23k | -19,94% |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | -1,19k | 72,67k | Derivative Exercise and Sale | 61,27 | 4,16k | - |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | 2,22k | 0,00 | Derivative Exercise and Retained Stock | - | 4,16k | 114,83% |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -1,37k | 83,94k | Derivative Exercise and Sale | 61,27 | 10,97k | - |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 10,97k | 19,80% |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | -12,87k | 788,42k | Derivative Exercise and Sale | 61,27 | 44,65k | - |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | 17,97k | 0,00 | Derivative Exercise and Retained Stock | - | 44,65k | 67,34% |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | -11,16k | 683,71k | Derivative Exercise and Sale | 61,27 | 14,17k | - |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | 9,88k | 0,00 | Derivative Exercise and Retained Stock | - | 14,17k | 230,70% |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | -1,37k | 84,18k | Derivative Exercise and Sale | 61,27 | 5,02k | - |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | 5,02k | 0,00 | Derivative Exercise and Retained Stock | - | 5,02k | - |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | -8,38k | 513,26k | Derivative Exercise and Sale | 61,27 | 22,19k | - |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | 9,44k | 0,00 | Derivative Exercise and Retained Stock | - | 22,19k | 74,02% |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 91,00 | 5,24k | Derivative Exercise and Retained Stock | 57,60 | 9,16k | 1,00% |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -2,05k | 9,55k | Derivative Exercise and Sale | 57,60 - 62,26 | 9,16k | - |
| 2025-12-15 | Mr. Michael D. HutchinsonInitié | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 6,80k | 19,98% |
| 2025-12-15 | Mr. Michael D. HutchinsonInitié | -1,12k | 70,75k | Derivative Exercise and Sale | 63,06 | 6,80k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 2,09k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | -269,00 | 16,96k | Derivative Exercise and Sale | 63,06 | 2,09k | - |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 551,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,07k | 6,47% |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -416,00 | 26,23k | Derivative Exercise and Sale | 63,06 | 9,07k | - |
| 2025-11-18 | Ms. Brooke Elizabeth StoryIndependent Director | -250,00 | 13,49k | Vente | 53,94 | 6,23k | -3,86% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 366,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,52k | 4,49% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -277,00 | 15,35k | Derivative Exercise and Sale | 55,43 | 8,52k | - |
| 2025-08-25 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,50k | 84,75k | Vente | 56,50 | 9,03k | -14,25% |
| 2025-06-15 | Mr. James Christopher BarryIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 4,36k | 221,68% |
| 2025-06-15 | Mr. James Christopher BarryIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 4,36k | - |
| 2025-06-15 | Mr. William A. KozyChairman of Board | 4,26k | 0,00 | Derivative Exercise and Retained Stock | - | 32,57k | 15,05% |
| 2025-06-15 | Mr. William A. KozyChairman of Board | -581,00 | 26,59k | Derivative Exercise and Sale | 45,76 | 32,57k | - |
| 2025-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 9,06k | 49,63% |
| 2025-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 9,06k | - |
| 2025-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 10,53k | 39,96% |
| 2025-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 10,53k | - |
| 2025-06-15 | Dr. Sharon O'KaneIndependent Non-Executive Director | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 11,30k | 19,06% |
| 2025-06-15 | Dr. Sharon O'KaneIndependent Non-Executive Director | -1,61k | 73,49k | Derivative Exercise and Sale | 45,76 | 11,30k | - |
| 2025-06-15 | Mr. Ahmet TezelChief Innovation Officer | 1,94k | 0,00 | Derivative Exercise and Retained Stock | - | 1,94k | - |
| 2025-06-15 | Mr. Ahmet TezelChief Innovation Officer | -1,03k | 47,22k | Derivative Exercise and Sale | 45,76 | 1,94k | - |
| 2025-06-15 | Mr. Peter Marshall WilverIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 6,74k | 80,55% |
| 2025-06-15 | Mr. Peter Marshall WilverIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 6,74k | - |
| 2025-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 11,75k | 34,37% |
| 2025-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 11,75k | - |
| 2025-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 6,48k | 86,48% |
| 2025-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 6,48k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.